Fanconi Anemia: Overview of the Disease and the Role of Hematopoietic Transplantation

Journal of Pediatric Hematology/Oncology

Volumn 37, Issue 5, 2015, Pages 335-343

  Schifferli, Alexandra ^a   Kühne, Thomas ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

aplastic anemia; DNA repair; Fanconi anemia; fludarabine; HSCT

Indexed keywords

ANDROGEN; ANTIINFLAMMATORY AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; DEVELOPMENTAL DISORDER; DIFFERENTIAL DIAGNOSIS; DONOR; FANCONI ANEMIA; FLOW CYTOMETRY; GENE MUTATION; GENE THERAPY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTORY OF MEDICINE; HUMAN; IMMUNOBLOTTING; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RELATED DONOR; REVIEW; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; UNRELATED DONORS; HUMANS; METHODS; TRANSPLANTATION CONDITIONING;

FANCONI ANEMIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; TRANSPLANTATION CONDITIONING;

EID: 84940102589     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000374     Document Type: Review

References (110)

1. Bagby GC, Alter BP. Fanconi anemia. Sem Hematol. 2006; 43:147-156.
2. Fanconi G. Familiar infantile pernicious anemia (pernicious blood smear and constitution). Jahrbuch Kinderheild. 1927;117:257-280.
3. Verlander PC, Kaporis A, Liu Q, et al. Carrier frequency of the IVS4+4 A-T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population. Blood. 1995;86: 4034-4038.
4. Rosendorff J, Bernstein R, Macdougall L, et al. Fanconi anemia: another disease of unusually high prevalence in the Afrikaans population of South Africa. Am J Med Genet. 1987;27:793-797.
5. Swift M. Fanconi's anaemia in the genetics of neoplasia. Nature. 1971;230:370-373.
6. Mathew CG. Fanconi anaemia genes and susceptibility to cancer. Oncogene. 2006;25:5875-5884.
7. Gluckman E. Radiosensitivity in Fanconi anemia: application to the conditioning for bone marrow transplantation. Radiother Oncol. 1990;18(suppl 1):88-93.
8. Berger R, Bernheim A, Gluckman E, et al. In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anaemia patients. Br J Haematol. 1980;45:565-568.
9. Giampietro PF, Verlander PC, Davis JG, et al. Diagnosis of Fanconi anemia in patients without congenital malformations: an International Fanconi Anemia Registry study. Am J Med Genet. 1997;68:58-61.
10. Wajnrajch MP, Gertner JM, Huma Z, et al. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics. 2001;107: 744-754.
11. Alter BP, Frissora CL, Halperin DS, et al. Fanconi's anaemia and pregnancy. Br J Haematol. 1991;77:410-418.
12. Dokal I. The genetics of Fanconi's anaemia. Baillieres Best Pract Res Clin Haematol. 2000;13:407-425.
13. Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood. 2003;101:1249-1256.
14. Faivre L, Guardiola P, Lewis C, et al. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group. Blood. 2000;96:4064-4070.
15. Koc A, Pronk JC, Alikasifoglu M, et al. Variable pathogenicity of exon 43del (FAA) in four Fanconi anaemia patients within a consanguineous family. Br J Haematol. 1999;104: 127-130.
16. Dokal I, Chase A, Morgan NV, et al. Positive diepoxybutane test in only one of two brothers found to be compound heterozygotes for Fanconi's anaemia complementation group C mutations. Br J Haematol. 1996;93:813-818.
17. Butturini A, Gale RP, Verlander PC, et al. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood. 1994;84:1650-1655.
18. Auerbach AD, Allen RG. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogenet. 1991;51:1-12.
19. Rosselli F, Sanceau J, Gluckman E, et al. Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha. Blood. 1994; 83:1216-1225.
20. Dufour C, Corcione A, Svahn J, et al. TNF-alpha and IFNgamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro. Blood. 2003;102:2053-2059.
21. Rathbun RK, Faulkner GR, Ostroski MH, et al. Inactivation of the Fanconi anemia group. C gene augments interferongamma-induced apoptotic responses in hematopoietic cells. Blood. 1997;90:974-985.
22. Auerbach AD. A test for Fanconi's anemia. Blood. 1988;72: 366-367.
23. German J, Schonberg S, Caskie S, et al. A test for Fanconi's anemia. Blood. 1987;69:1637-1641.
24. Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol. 1993;21:731-733.
25. Auerbach AD. Fanconi anemia and its diagnosis. Mutat Res. 2009;668:4-10.
26. Auerbach AD, Sagi M, Adler B. Fanconi anemia: prenatal diagnosis in 30 fetuses at risk. Pediatrics. 1985;76:794-800.
27. Dutrillaux B, Aurias A, Dutrillaux AM, et al. The cell cycle of lymphocytes in Fanconi anemia. Hum Genet. 1982;62: 327-332.
28. Seyschab H, Friedl R, Sun Y, et al. Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia. Blood. 1995;85:2233-2237.
29. Shimamura A, Montes de Oca R, Svenson JL, et al. A novel diagnostic screen for defects in the Fanconi anemia pathway. Blood. 2002;100:4649-4654.
30. Chandra S, Levran O, Jurickova I, et al. A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients. Mol Ther. 2005;12:976-984.
31. Gluckman E, Wagner JE. Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome. BMT. 2008;41:127-132.
32. Resnick IB, Kondratenko I, Togoev O, et al. Nijmegen breakage syndrome: clinical characteristics and mutation analysis in eight unrelated Russian families. J Pediatr. 2002; 140:355-361.
33. Moses RE. DNA damage processing defects and disease. Annu Rev Genomics Hum Genet. 2001;2:41-68.
34. Futaki M, Liu JM. Chromosomal breakage syndromes and the BRCA1 genome surveillance complex. Trends Mol Med. 2001;7:560-565.
35. Bogliolo M, Schuster B, Stoepker C, et al. Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am J Hum Genet. 2013;92:800-806.
36. Taniguchi T, D'Andrea AD. Molecular pathogenesis of Fanconi anemia: recent progress. Blood. 2006;107:4223-4233.
37. Wijker M, Morgan NV, Herterich S, et al. Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. Eur J Hum Genet. 1999;7:52-59.
38. Magdalena N, Pilonetto DV, Bitencourt MA, et al. Frequency of Fanconi anemia in Brazil and efficacy of screening for the FANCA 3788-3790del mutation. Braz J Med Biol Res. 2005;38:669-673.
39. Tischkowitz M, Ameziane N, Waisfisz Q, et al. Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia. Br J Haematol. 2003;123:469-471.
40. Turner N, Tutt A, Ashworth A. Hallmarks of 'BRCAness' in sporadic cancers. Nat Rev Cancer. 2004;4:814-819.
41. Taniguchi T, Tischkowitz M, Ameziane N, et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med. 2003;9:568-574.
42. Marsit CJ, Liu M, Nelson HH, et al. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene. 2004;23:1000-1004.
43. Gross M, Hanenberg H, Lobitz S, et al. Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular selfcorrection. Cytogenet Genome Res. 2002;98:126-135.
44. Lo Ten Foe JR, Kwee ML, Rooimans MA, et al. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet. 1997;5:137-148.
45. Waisfisz Q, Morgan NV, Savino M, et al. Spontaneous functional correction of homozygous Fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nat Genet. 1999;22:379-383.
46. MacMillan ML, Auerbach AD, Davies SM, et al. Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial. Br J Haematol. 2000;109:121-129.
47. Pavlatos AM, Fultz O, Monberg MJ, et al. Review of oxymetholone: a 17 alpha-alkylated anabolic-androgenic steroid. Clin Ther. 2001;23:789-801; discussion 771.
48. Guinan EC, Lopez KD, Huhn RD, et al. Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with Fanconi anemia. J Pediat. 1994;124:144-150.
49. Rackoff WR, Orazi A, Robinson CA, et al. Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study. Blood. 1996;88:1588-1593.
50. Wagner JE, Eapen M, MacMillan ML, et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood. 2007;109:2256-2262.
51. Gordon-Smith EC1, Rutherford TR. Fanconi anemia: constitutional aplastic anemia. Semin Hematol. 1991;28:104-112.
52. Scagni P, Saracco P, Timeus F, et al. Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia. Haematologica. 1998;83:432-437.
53. Alter BP. Fanconi's anemia and malignancies. Am J Hematol. 1996;53:99-110.
54. Deeg HJ, Socie G, Schoch G, et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood. 1996;87:386-392.
55. Rosenberg PS, Socié G, Alter BP, et al. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did or did not receive transplants. Blood. 2005; 105:67-73.
56. Potter NU, Sarmousakis C, Li FP. Cancer in relatives of patients with aplastic anemia. Cancer Genet Cytogenet. 1983; 9:61-65.
57. Storb R, Thomas ED, Buckner CD, et al. Allogeneic marrow grafting for treatment of aplastic anemia. Blood. 1974;43: 157-180.
58. Barrett AJ, Brigden WD, Hobbs JR, et al. Successful bone marrow transplant for Fanconi's anaemia. Br Med J 1977; 12:420-422.
59. Deeg HJ, Storb R, Thomas ED, et al. Fanconi's anemia treated by allogeneic marrow transplantation. Blood. 1983; 61:954-959.
60. Farzin A, Davies SM, Smith FO, et al. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience. Br J Haematol. 2007;136:633-640.
61. Guardiola P, Socié G, Li X, et al. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA identical sibling donors: risk factors and influence on outcome. Blood. 2004;103:73-77.
62. Guardiola P, Pasquini R, Dokal I, et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood. 2000;95:422-429.
63. MacMillan ML, Wagner JE. Haematopoeitic cell transplantation for Fanconi anaemia-when and how? Br J Haematol. 2010;149:14-21.
64. Socie G, Devergie A, Girinski T, et al. Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol. 1998;103:249-255.
65. Gluckman E, Auerbach AD, Horowitz MM, et al. Bone marrow transplantation for Fanconi anemia. Blood. 1995;86: 2856-2862.
66. Peffault de Latour R, Porcher R, Dalle JH, et al. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the EBMT experience. Blood. 2013;122:4279-4286.
67. Flowers ME, Doney KC, Storb R, et al. Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience. Bone Marrow Transplant. 1992;9:167-173.
68. Zanis-Neto J, Ribeiro RC, Medeiros C, et al. Bone marrow transplantation for patients with Fanconi anemia: a study of 24 cases from a single institution. Bone Marrow Transplant. 1995;15:293-298.
69. Flowers MED, Zanis J, Pasquini R, et al. Marrow transplantation for Fanconi anaemia: conditioning with reduced doses of cyclophosphamide without radiation. Br J Haematol. 1996;92:699-706.
70. Medeiros C, Zanis-Neto J, Pasquini R. Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning. Bone Marrow Transplant. 1999;24:849-852.
71. Zanis-Neto J, Flowers ME, Medeiros CR, et al. Low-dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anaemia. Haematol. 2005;130:99-106.
72. Bonfim CM, de Medeiros CR, Bitencourt MA, et al. HLAmatched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide. Biol Blood Marrow Transplant. 2007; 13:1455-1460.
73. Ayas M, Al-Jefri A, Al-Seraihi A, et al. Matched-related allogeneic stem cell transplantation in Saudi patients with Fanconi anemia: 10 year's experience. Bone Marrow Transplant. 2008;42(suppl 1):45-48.
74. Torjemane L, Ladeb S, Ben Othman T, et al. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning. Pediatr Blood Cancer. 2006;46:496-500.
75. Socié G, Devergie A, Girinski T, et al. Transplantation for Fanconi's anaemia: long term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol. 1998;103:249-255.
76. Kohli-Kumar M, Morris C, DeLaat C, et al. Bone marrow transplantation in Fanconi anemia using matched sibling donors. Blood. 1994;84:2050-2054.
77. Ayas M, Solh H, Mustafa MM, et al. Bone marrow transplantation from matched siblings in patients with fanconi anemia utilizing low-dose cyclophosphamide, thoracoabdominal radiation and antithymocyte globulin. Bone Marrow Transplant. 2001;27:139-143.
78. Ayas M, Al-Seraihi A, El-Solh H, et al. The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells. Biol Blood Marrow Transplant. 2012;18:627-632.
79. Tan PL, Wagner JE, Auerbach AD, et al. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatr Blood Cancer. 2006;46:630-636.
80. Socié G, Gluckman E, Raynal B, et al. Bone marrow transplantation for Fanconi anemia using low-dose cyclophosphamide/ thoracoabdominal irradiation as conditioning regimen: chimerism study by the polymerase chain reaction. Blood. 1993;82:2249-2256.
81. Locatelli F, Zecca M, Pession A, et al. Italian Pediatric Group. The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group. Haematologica. 2007;92: 1381-1388.
82. Shimada A, Takahashi Y, Muramatsu H, et al. Excellent outcome of allogeneic bone marrow transplantation for Fanconi anemia using fludarabine-based reduced-intensity conditioning regimen. Int J Hematol. 2012;95:675-679.
83. Stepensky P, Shapira MY, Balashov D, et al. Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning. Biol BloodMarrow Transplant. 2011;17:1282-1288.
84. Boulad F, Gillio A, Small TN, et al. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine based cytoreductive regimen and T-cell depleted related HLA mismatched peripheral blood stem cell grafts. Br J Haematol. 2000;111:1153-1157.
85. Chaudhury S, Auerbach AD, Kernan NA, et al. Fludarabinebased cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia. Br J Haematol. 2008;140:644-655.
86. Yabe H, Inoue H, Matsumoto S, et al. Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low dose irradiation, Fludarabine and cyclophosphamide in Fanconi anaemia. Br J Haematol. 2006;134:208-212.
87. Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174-1178.
88. Ballen KK, Hicks J, Dharan B, et al. Racial and ethnic composition of volunteer cord blood donors: comparison with volunteer unrelated marrow donors. Transfusion. 2002; 42:1279-1284.
89. Rocha V, Wagner JE, Sobocinski KA, et al. Graft versus host disease in children who have received a cord blood or bone marrow transplant from HLA identical sibling. N Engl JMed. 2000;342:1846-1854.
90. Wagner JE, Gluckman E. Umbilical cord blood transplantation: the first 20 years. Semin Hematol. 2010;47:3-12.
91. Gluckman E, Rocha V, Ionescu I, et al. Eurocord-Netcord and EBMT. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant. 2007;13: 1073-1082.
92. Verlinsky Y, Rechitsky S, Schoolcraft W, et al. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA. 2001;285:3130-3133.
93. Grewal SS, Kahn JP, Macmillan ML. Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis. Blood. 2004;103:1147-1151.
94. Damewood MD. Ethical implications of a new application of preimplantation diagnosis. JAMA. 2001;285:3143-3144.
95. Reisner Y, Hagin D, Martelli MF. Haploidentical hematopoietic transplantation: current status and future perspectives. Blood. 2011;118:6006-6017.
96. Elhasid R, Ben Arush MW, Katz T, et al. Successful haploidentical bone marrow transplantation in Fanconi anemia. Bone Marrow Transplant. 2000;26:1221-1223.
97. Rossi G, Giorgiani G, Comoli P, et al. Successful T-celldepleted, related haploidentical peripheral blood stem cell transplantation in a patient with Fanconi anaemia using a fludarabine-based preparative regimen without radiation. Bone Marrow Transplant. 2003;31:437-440.
98. Thakar MS, Bonfim C, Sandmaier BM, et al. Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia. Pediatr Hematol Oncol. 2012;29:568-578.
99. Zecca M, Strocchio L, Pagliara D, et al. HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia. Biol Blood Marrow Transplant. 2014;20:571-576.
100. Wang L, Romero M, Ratajczak P, et al. Increased apoptosis is linked to severe acute GVHD in patients with Fanconi anemia. Bone Marrow Transplant. 2013;48:849-853.
101. Mankad A, Taniguchi T, Cox B, et al. Natural gene therapy in monozygotic twins with Fanconi anemia. Blood. 2006;107: 3084-3090.
102. Liu JM, Kim S, Read EJ, et al. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Hum Gene Ther. 1999;10:2337-2346.
103. Kelly PF, Radtke S, Kalle C, et al. Stem cell collection and gene transfer in fanconi anemia. Mol Ther. 2007;15:211-219.
104. Gush KA, Fu KL, Grompe M, et al. Phenotypic correction of Fanconi anemia group C knockout mice. Blood. 2000;95: 700-704.
105. Aiuti A, Slavin S, Aker M, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science. 2002;296:2410-2413.
106. Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272:263-267.
107. Galimi F, Noll M, Kanazawa Y, et al. Gene therapy of Fanconi anaemia by lentivectors. Blood. 2002;100:2732-2736.
108. Si Y, Pulliam AC, Linka Y, et al. Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-stem cells. Blood. 2008;112:4458-4465.
109. Li J, Sejas DP, Zhang X, et al. TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells. J Clin Invest. 2007;117:3283-3295.
110. Mehta PA, Svahn J, Davies SM, et al. Etanercept treatment in Fanconi anaemia; combined US and Italian experience. Br J Haematol. 2012;158:809-811.